Bonk (NASDAQ:BNKK) Releases Earnings Results

Bonk (NASDAQ:BNKK) released its quarterly earnings data on Tuesday. The company reported ($8.27) earnings per share for the quarter, FiscalAI reports. The company had revenue of $1.82 million for the quarter.

Bonk Stock Up 3.6%

Shares of BNKK traded up $0.09 on Tuesday, hitting $2.61. The company’s stock had a trading volume of 23,487 shares, compared to its average volume of 1,378,661. The business has a fifty day moving average of $3.58. Bonk has a fifty-two week low of $2.31 and a fifty-two week high of $46.90. The stock has a market capitalization of $13.73 million, a price-to-earnings ratio of -0.34 and a beta of 1.93.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. State Street Corp bought a new stake in shares of Bonk during the fourth quarter worth $33,000. Steward Partners Investment Advisory LLC bought a new stake in Bonk in the 4th quarter valued at $37,000. Jane Street Group LLC bought a new stake in Bonk in the 4th quarter valued at $96,000. Finally, Geode Capital Management LLC acquired a new position in Bonk in the 4th quarter worth $128,000. Institutional investors own 12.55% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have weighed in on BNKK shares. Weiss Ratings reiterated a “sell (d-)” rating on shares of Bonk in a report on Friday. Wall Street Zen raised shares of Bonk to a “sell” rating in a research report on Saturday, December 13th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Sell”.

Bonk Company Profile

Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.